Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
Partner Content Partner Content Challenges including Funding and Lack of Incentives Hinder A... Explore Challenges in Antibiotic Research
Partner Content Partner Content Registration Officially Opens for the 21st Annual Superbugs ... Registration Opens for 21st Superbugs & Superdrugs 2019
Events Partner Content 21st Annual Superbugs & Superdrugs Conference 21st Annual Superbugs & Superdrugs Conference
Partner Content Partner Content W. J. Wiess and A.S. Lynch invitation to Superbugs & Sup... SMi Group reports: William J.
News UK government kick-starts AMR research with £10m grant Tackling AMR is long-term government goal
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
